Author

Anna P. Mullard

Observed names: A Mullard, A P Mullard, A. Mullard, A. P. Mullard, A.P. Mullard, Anna Mullard, Anna P Mullard

Institution: Betsi Cadwaladr University Health Board

Observed institutions: Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Clatterbridge Cancer Centre NHS Foundation Trust, Ysbyty Gwynedd Hospital NHS Trust

ORCID: 0000-0001-5284-1088

Observed ORCID: 0000-0001-5284-1088

OpenAlex ID: A5026680419

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

2023 · Janet E Brown, Kara-Louise Royle, et al. · The Lancet Oncology · 92

PDF

Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation

2015 · Janette Greenhalgh, Adrian Bagust, et al. · Health Technology Assessment · 45

PDF

The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high‐grade serous ovarian cancer: a national retrospective audit

2021 · B Frugtniet, S Morgan, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 19

PDF

Integration of rapid PCR testing as an adjunct to NGS in diagnostic pathology services within the UK: evidence from a case series of non-squamous, non-small cell lung cancer (NSCLC) patients with follow-up

2022 · Alison Finall, Gareth Davies, et al. · Journal of Clinical Pathology · 18

A review of systemic anticancer therapy in disease palliation

2017 · C M Usborne, A P Mullard · British Medical Bulletin · 17

Checklists for Complications During Systemic Cancer Treatment Shared by Patients, Friends, and Health Care Professionals: Prospective Interventional Cohort Study

2020 · Helen V Jones, Harry Smith, et al. · JMIR mhealth and uhealth · 16

PDF

Intractable Malignant Ascites: An Alternative Management Option

2011 · Anna P. Mullard, Jill M. Bishop, et al. · Journal of Palliative Medicine · 10

Venous thromboembolism in malignancy

2014 · Anna Mullard, Helen Innes · Clinical Medicine · 9

PDF

Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres

2014 · A. P. Mullard, V. Misra, et al. · Supportive Care in Cancer · 6

Digital Remote Monitoring Using an mHealth Solution for Survivors of Cancer: Protocol for a Pilot Observational Study

2024 · Pasquale F Innominato, Jamie H Macdonald, et al. · JMIR Research Protocols · 3

Evaluating process and effectiveness of a low-intensity CBT intervention for women with gynaecological cancer (the EPELIT Trial)

2021 · Nicholas J. Hulbert-Williams, Lee Hulbert-Williams, et al. · AMRC Open Research · 2

Correction: Checklists for Complications During Systemic Cancer Treatment Shared by Patients, Friends, and Health Care Professionals: Prospective Interventional Cohort Study

2020 · Helen V Jones, Harry Smith, et al. · JMIR mhealth and uhealth · 1

A retrospective comparison of frontline platinum in non-squamous non-small-cell lung cancer in North Wales over 9 years

2019 · N. Wreglesworth, M. Chauhan, et al. · Lung Cancer · 1

Radical hypofractionated radiotherapy for the treatment of non-small-cell lung cancer using 52·5–55 Gy in 20 fractions: the North Wales Cancer Centre experience

2015 · Niladri Ghosal, Anna P. Mullard, et al. · Journal of Radiotherapy in Practice · 1

103P Chemotherapy-induced neutropaenia as a marker for overall survival (OS) in non-small cell lung cancer (NSCLC) patients undergoing gemcitabine/carboplatin (GemCarbo) chemotherapy: A 9-year real-life data

2020 · Y.F. Clark, J. Vangara, et al. · Annals of Oncology

Waiting for treatment: an audit of the waiting time for mutational biomarker results in the diagnosis of non-small cell lung cancer

2020 · T. Woolley, B. Corney, et al. · Lung Cancer

A Prospective Phase I/II Study of Docetaxel, Cisplatin and Continuous Capecitabine in Advanced Oesophago-Gastric Cancer (NWCOG-3)

2018 · S. Gollins, S. Massalha, et al. · Clinical Oncology

141: Small cell lung cancer: Is there a role for chemotherapy in patients with poor performance status?

2017 · S. Massalha, A. Mullard, et al. · Lung Cancer

Quality assessment of included studies